• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Cardinal Energy Ltd Ord
Dorchester Minerals, L.P. - Common Units Representing Limited
Mechanics Bancorp - Class A Common Stock
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Zivo Bioscience, Inc. - Common Stock (OP:ZIVO)

6.500 -0.014 (-0.21%)
Delayed Quote Updated: 3:38 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,888
Open 6.720
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 6.514
Today's Range 6.500 - 6.908
52wk Range 1.105 - 17.50
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
June 26, 2026
From Virtual Investor Conferences
Via GlobeNewswire
News headline image
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th
June 23, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

52-Week Range 62.9% below 52-week high
6.500
1.1052W Low 17.5052W High
1 Week 5.9% below 1-week high
6.501W Low 6.911W High

Zivo Bioscience, Inc. - Common Stock (ZIVO) traded between $1.10 and $17.50 over the past 52 weeks and last traded at $6.50, 62.9% below its 52-week high. Over the past week it ranged between $6.50 and $6.91.

Past 12 Months
-0.2%
+94.0%
+57.0%
+208.8%
-34.4%
-53.5%
1W -$0.01
1M +$3.15
3M +$2.36
6M +$4.39
YTD -$3.41
1Y -$7.49

ZIVO was -53.5% over the past year, +208.8% over six months, -34.4% year to date, -0.2% in the last week.

12 Months vs Market
ZIVO
-53.5%
DIA
+13.0%
SPY
+15.5%
QQQ
+18.3%
IWM
+10.4%

Over the past 12 months ZIVO returned -53.5% versus DIA (Dow) +13.0%, SPY (S&P 500) +15.5%, QQQ (Nasdaq 100) +18.3% and IWM (Russell 2000) +10.4%.

Volume & Liquidity 5.86× 3-mo avg
Today 1,888 3-mo avg 322.0
1W
951.0
1M
619.0
3M
322.0
6M
2.0K
YTD
2.4K
1Y
2.2K

ZIVO most recently traded 1,888 shares against a 3-month average daily volume of 322.0.

More News

Read More
News headline image
ZIVO Stock Earnings: Zivo Bioscience Reported Results for Q2 2024 ↗
August 16, 2024
Via InvestorPlace
News headline image
ZIVO Bioscience Secures Commercial-Scale Manufacturing Agreement with Cyanotech Corporation for Zivolife™ Algal Biomass
April 06, 2026
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Provides Special Letter to Shareholders
March 27, 2026
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry
June 20, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 06, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience to Present at The Microcap Conference 2025
January 22, 2025
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens
August 23, 2024
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08, 2024
From ZIVO Bioscience, Inc.
Via Business Wire

Frequently Asked Questions

Is Zivo Bioscience, Inc. - Common Stock publicly traded?
Yes, Zivo Bioscience, Inc. - Common Stock is publicly traded.
What exchange does Zivo Bioscience, Inc. - Common Stock trade on?
Zivo Bioscience, Inc. - Common Stock trades on the OTC Traded
What is the ticker symbol for Zivo Bioscience, Inc. - Common Stock?
The ticker symbol for Zivo Bioscience, Inc. - Common Stock is ZIVO on the OTC Traded
What is the current price of Zivo Bioscience, Inc. - Common Stock?
The current price of Zivo Bioscience, Inc. - Common Stock is 6.500
When was Zivo Bioscience, Inc. - Common Stock last traded?
The last trade of Zivo Bioscience, Inc. - Common Stock was at 10/16/26 03:38 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap